Price (GBX)
127.00 -4.87%
AVCTORD 10P
Track 1 instrument
Open / Last close
- / 133.50
High / Low
132.50 / 126.00
Bid / Offer
125.00 / 129.00
Turnover
-
Special Condition: -
Trading Status: Regular Trading
As at 05.08.20 11:57:11 - All data delayed at least 15 minutes

Avacta Group PLC instruments

Select instrument to view
Equity (1)
Code Instrument name Price Change Type Documentation
AVCTORD 10P127.00
GBX
-4.87%Equity-

Price information

What's this?
Open price
-
Previous close price / date
133.50 / 04 August 2020
Volume
964,978
Turnover
-
52 week range
14.00 / 202.00
YTD return
621.62
1 year return
444.90

Instrument information

What's this?
Instrument market cap (£m)
332.62
Earnings per share
-0.13
Dividend (yield)
- %
Issue date
26 January 2016
ISIN
GB00BYYW9G87
SEDOL
BYYW9G8
Market identifier code (MIC)
AIMX
Country of share register
GB
Market segment
ASX1
Trading service
SETSqx
Date Time Price CurrencyVolume Trade ValueTrade type Trade flag MIC
05.08.20 10:59:25 128.00 GBX 10,000 12,800.00 Off-Book LRGS AIMX
05.08.20 11:51:41 125.70 GBX 542 681.29 Off-Book - AIMX
05.08.20 11:51:00 127.56 GBX 1,000 1,275.60 Off-Book - AIMX
05.08.20 11:50:49 125.70 GBX 1,210 1,520.97 Off-Book - AIMX
05.08.20 11:50:29 127.35 GBX 778 990.74 Off-Book - AIMX

Equity Research

from Avacta Group PLC
SP Angel Healthcare Conditions

Avacta (AVCT.L): Adeptrix COVID-19 Diagnostic Test update | Diaceutics (DXRX.L): New contract win

View report
SP Angel Healthcare Conditions

Novacyt (NCYT.L): Trading update | Avacta (AVCT.L): COVID-19 wastewater detection sensor collaboration with Integumen

View report
Morning Note – 24 June 2020

Allergy Therapeutics (AGY.L): Corp Profit upgrade | Aukett Swanke (AUK.L): Corp Interim results | Avacta (AVTG.L): Corp SARS-CoV-2 point-of care antigen test – update | discoverIE (DSCV.L): Corp Resilient, flexible and well positioned for growthiomart (IOMG.L): Corp Finals to ...

View report
Morning Note – 18 June 2020

Access Intelligence (ACCI.L): Corp Half-year trading update | Avacta (AVTG.L): Corp Potential COVID-19 therapeutic – progress | Synairgen (SNG): Corp COVID-19 home setting trial amendments | Tremor (TRMR): Corp Strong Q1 before large COVID-19 impacts in Q2

View report
Morning Note – 9 June 2020

Avacta (AVTG.L): Corp | Europa Oil & Gas (EOG): Corp | Omega Diagnostics (ODX): Corp | Redcentric (RCN): Corp | Telit (TCM): Corp

View report

Latest reports

from Avacta Group PLC
Avacta Annual Report and Accounts 2019
file

Contacts

from Avacta Group PLC
Avacta's PR agency
Yellow Jersey PR
atAvacta Group PLC
+44 (0)20 3004 9512.
avacta@yellowjerseypr.com
Issuer presentations live and on demand
Watch on Spark Live